Factors for a Successful COVID-19 Vaccination Program

The coronavirus outbreak continues to rapidly evolve and as the world anxiously awaits a vaccine to combat the SARS-CoV-2 virus, deliberate consideration of crucial factors is needed to launch a successful vaccination program aimed at expeditiously servicing the U.S. population.

In this webinar, you’ll hear from career officials and industry experts from CGI and Johns Hopkins University who will discuss crucial factors in the successful development, launch and distribution of a successful COVID-19 vaccination program. The discussion, brought to you and moderated by HIMSS, will feature Rehana Wolfe, Director and Consulting Expert with CGI, and Lois Privor-Dumm, Sr. Advisor, Policy, Advocacy & Communications Director, Adult Vaccines at Johns Hopkins Bloomberg School of Public Health. Together, Lois and Rehana will engage in a lively discussion aimed at creating awareness of the complexity, opportunities and challenges in vaccinating the US population during a pandemic.

Learning Points:

The underlying differences in routine versus pandemic immunization
A detailed understanding of the health ecosystem, key players and factors crucial to the distribution and administration of a successful COVID-19 vaccine
Public education – Crucial information the public needs given the possibility that more than one vaccine could potentially be approved for use
Strategies for gaining public confidence and trust in vaccines
How we can measure success in the COVID-19 immunization programs

Lois Privor-Dumm, IMBA

Senior Advisor, Policy, Advocacy & Communications & Director, Adult Vaccines
International Vaccine Access Center Johns Hopkins School of Public Health

Bio info: Lois Privor-Dumm is Senior Advisor, Policy Advocacy & Communications and Director, Adult Vaccines at Johns...

Lois Privor-Dumm is Senior Advisor, Policy Advocacy & Communications and Director, Adult Vaccines at Johns Hopkins International Vaccine Access Center. She has worked with more than 70 countries to help accelerate new vaccine introductions and supports global and country level partners to plan for introductions of COVID-19 vaccine. Her research focuses on health policy and drivers of decision-making and implementation of vaccine programs. She contributed to the Johns Hopkins Center For Health Security’s Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States and report on the Public’s Role in COVID-19 Vaccination and currently is working in Baltimore City evaluating a influenza vaccine initiative for older adults living in senior housing buildings that will measure perceptions and attitudes relating to vaccines and vaccination.

Rehana Wolfe

Director, Consulting Expert
CGI

Bio info: Rehana Wolfe has over 15 years of global biopharmaceutical experience spanning across geographies and therapeutic...

Rehana Wolfe has over 15 years of global biopharmaceutical experience spanning across geographies and therapeutic areas. She is a global expert in vaccines commercialization in both public and private markets. She helps CGI clients assess and develop business strategies that deliver growth, prioritize strategic and technology solutions for go-to market strategies.
Before joining CGI, Rehana served as Director, Developing World, Vaccines at Pfizer for 4 years where she successfully converted a unique vaccine business segment into a strong growth driver via focused commercial strategies and multilateral stakeholder engagements. Prior to her pharmaceutical career, Rehana worked in the media and education industries as well as a diplomatic mission. Rehana currently serves as a President for Wings for Success and has an MA in Strategic Communication from Villanova University.